Skip to main content
search

Early Clinical

Sign up

Latest resources

Featured resource

Upcoming early clinical webinars

Webinar

Final ICH M15 Guidance: Aligning MIDD with Global Regulatory Expectations

May 5, 2026 – 11am ET - 12pm ET
Webinar

Pharmacometrics Under Pressure

May 6, May 15 – 10:00 - 11:00am ET
Webinar

Explore Smarter, Faster PK/PD with Phoenix

May 12, 2026 – 10-11 AM ET/CET/JST

Latest early clinical blogs

Meet our experts at the following events

All early clinical resources

Understanding LC/MS/MS

Certara Services, Blog, Knowledge Base

QSP at an Inflection Point: Scaling Impact

Certara Products - Certara IQ, Modeling and Simulation - QSP, Blog

Allometric Approach in pharmacokinetics when and how to use it

Certara Products - Phoenix, Certara University, Clinical Pharmacology, Modeling and Simulation - PK/PD, Webinar

From Models to Impact: What QSPC 2026 Revealed About the Future of Drug Development

Certara Products - Certara IQ, Certara Products - Simcyp, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, New Approach Methodologies (NAMs), Blog

DIDB® Concomitant Meds Navigator

Drug Development, Drug-Drug Interactions (DDI), Fact Sheet

3 Things You Should Know About ADaM Standards 

CDISC, Certara Products, Certara Products - Pinnacle 21, Data Standards, Blog

Top 10 Benefits of Simcyp® Simulator for Drug Development

Certara Products - Simcyp, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Blog

ADC Dose Optimization: Applying Model-Informed Strategies in Development

ADC, Biologics, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Blog

Mean Residence Time (MRT): Understanding How Long Drug Molecules Stay in the Body

Modeling and Simulation - PK/PD, Blog, Knowledge Base

When pharmacokinetics meets pharmacogenomics: Genetic Insights into Fluoxetine PK for Personalized Antidepressant Therapy

Certara Products - Phoenix, Certara University, Clinical Pharmacology, Modeling and Simulation - PK/PD, Webinar

PK Parameters Explained: From Cmax to Clearance (and Why It Matters for Development Decisions)

Certara Products - Phoenix, Clinical Pharmacology, Modeling and Simulation - PK/PD, Blog

Final ICH M15 Guidance: Aligning MIDD with Global Regulatory Expectations

Certara Products, Certara Products - Phoenix, Certara Products - Simcyp, Certara Services, Clinical Pharmacology, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Webinar
Sign up to newsletter

Why sign up? Because transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.